Westerveld H - Search Results

1

Brachytherapy training survey among radiation oncology residents in Europe.

Sturdza AE, Stephanides M, Jurgenliemk-Schulz I, Eriksen JG, Benstead K, Hoskin P, Vlad S, Escande A, Corradini S, Knoth J, Westerveld H, Tagliaferri L, Najari-Jamali D, Konat-Baska K, Plesinac V, Tan LT, Nout R, Strnad V, Niehoff P, Pieters BR, Tanderup K, Kamrava M. Sturdza AE, et al. Among authors: westerveld h. Radiother Oncol. 2022 Dec;177:172-178. doi: 10.1016/j.radonc.2022.10.030. Epub 2022 Oct 31. Radiother Oncol. 2022. PMID: 36328092

2

Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.

Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, Petrič P, Mahantshetty U, Dörr W, Pötter R. Kirchheiner K, et al. Among authors: westerveld h. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):88-95. doi: 10.1016/j.ijrobp.2014.01.032. Int J Radiat Oncol Biol Phys. 2014. PMID: 24725693

3

Intra-fraction uncertainties of MRI guided brachytherapy in patients with cervical cancer.

Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Westerveld H, Jürgenliemk-Schulz IM. Nomden CN, et al. Among authors: westerveld h. Radiother Oncol. 2014 Aug;112(2):217-20. doi: 10.1016/j.radonc.2014.08.010. Epub 2014 Sep 10. Radiother Oncol. 2014. PMID: 25216574

4

Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.

Westerveld H, de Leeuw A, Kirchheiner K, Dankulchai P, Oosterveld B, Oinam A, Hudej R, Swamidas J, Lindegaard J, Tanderup K, Pötter R, Kirisits C; EMBRACE Collaborative Group. Westerveld H, et al. Radiother Oncol. 2016 Sep;120(3):420-427. doi: 10.1016/j.radonc.2016.05.002. Epub 2016 May 26. Radiother Oncol. 2016. PMID: 27237058

5

Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.

de Boer P, Jürgenliemk-Schulz IM, Westerveld H, de Leeuw AAC, Dávila-Fajardo R, Rasch CRN, Pieters BR, Stalpers LJA. de Boer P, et al. Among authors: westerveld h. Radiother Oncol. 2017 May;123(2):306-311. doi: 10.1016/j.radonc.2017.04.005. Epub 2017 Apr 20. Radiother Oncol. 2017. PMID: 28434797

6

Defining a Leader Role curriculum for radiation oncology: A global Delphi consensus study.

Turner S, Seel M, Trotter T, Giuliani M, Benstead K, Eriksen JG, Poortmans P, Verfaillie C, Westerveld H, Cross S, Chan MK, Shaw T. Turner S, et al. Among authors: westerveld h. Radiother Oncol. 2017 May;123(2):331-336. doi: 10.1016/j.radonc.2017.04.009. Epub 2017 Apr 25. Radiother Oncol. 2017. PMID: 28455152

7

Evaluation of bi-objective treatment planning for high-dose-rate prostate brachytherapy-A retrospective observer study.

Maree SC, Luong NH, Kooreman ES, van Wieringen N, Bel A, Hinnen KA, Westerveld H, Pieters BR, Bosman PAN, Alderliesten T. Maree SC, et al. Among authors: westerveld h. Brachytherapy. 2019 May-Jun;18(3):396-403. doi: 10.1016/j.brachy.2018.12.010. Epub 2019 Feb 2. Brachytherapy. 2019. PMID: 30718176

8

AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.

Vaarwerk B, Hol MLF, Schoot RA, Breunis WB, de Win MML, Westerveld H, Fajardo RD, Saeed P, van den Brekel MW, Pieters BR, Strackee SD, Smeele LE, Merks JHM. Vaarwerk B, et al. Among authors: westerveld h. Radiother Oncol. 2019 Feb;131:21-26. doi: 10.1016/j.radonc.2018.10.036. Epub 2018 Dec 17. Radiother Oncol. 2019. PMID: 30773183

9

Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.

Schmid MP, Fokdal L, Westerveld H, Chargari C, Rohl L, Morice P, Nesvacil N, Mazeron R, Haie-Meder C, Pötter R, Nout RA; GEC-ESTRO GYN Working Group. Schmid MP, et al. Among authors: westerveld h. Radiother Oncol. 2020 Apr;145:36-44. doi: 10.1016/j.radonc.2019.11.005. Epub 2019 Dec 23. Radiother Oncol. 2020. PMID: 31874348

10

Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer.

Westerveld H, Nesvacil N, Fokdal L, Chargari C, Schmid MP, Milosevic M, Mahantshetty UM, Nout RA. Westerveld H, et al. Lancet Oncol. 2020 Mar;21(3):e157-e167. doi: 10.1016/S1470-2045(19)30855-1. Lancet Oncol. 2020. PMID: 32135119 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page